Novo Nordisk A/S
The HEOR Manager role involves building economic and clinical evidence to support new treatments reaching patients in Japan. The position requires preparing HTA submissions, negotiating with authorities like MHLW and C2H, and shaping HEOR and real-world evidence plans for assigned products. This role influences market access at launch and the long-term value of products for patients with serious chronic diseases.
Headquarters
Alle, Central Jutland, Denmark
Company Size
10001+ employees
Founded
1923
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark, with the stated purpose of driving change to defeat diabetes and other serious chronic diseases. It researches, develops, manufactures and markets pharmaceutical products and medical devices across diabetes care, obesity, haemophilia, growth disorders and other endocrine conditions, and is widely known for its insulin and GLP‑1 therapies. Combining extensive R&D, large‑scale manufacturing and global commercial reach, Novo Nordisk emphasizes patient‑centred care, access programs and sustainability in its work to improve outcomes for people with chronic disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novo Nordisk A/S.
Novo Nordisk A/S didn’t post a salary, so this is our estimate from similar listings.
18% above the average for this role
Director, HEOR Strategy Eyecare, International Launch Lead
AbbVie
Global Health Economics & Outcomes Research (HEOR) Director
Ipsen
Director, HEOR & RWE, Europe
Revolution Medicines
HEOR Research Scientist
Eli Lilly and Company
Global Health Economics & Outcomes Research (HEOR) Senior Manager
lifelancer
Global HEOR Strategy Lead
Denali Therapeutics